A. Balcioglu et Rj. Wurtman, EFFECTS OF PHENTERMINE ON STRIATAL DOPAMINE AND SEROTONIN RELEASE IN CONSCIOUS RATS - IN-VIVO MICRODIALYSIS STUDY, International journal of obesity, 22(4), 1998, pp. 325-328
OBJECTIVE: To measure the effects of phentermine, an appetite supressa
nt, on the release of brain dopamine (DA) and serotonin (5-HT) into st
riatal dialysates of freely moving rats. DESIGN: Microdialysis and hig
h performance liquid chromatography. SUBJECTS: Unanesthetized rats. ME
ASUREMENTS: Samples collected every 20 min were assayed for both neuro
transmitters in a single run, using high performance liquid chromatogr
aphy with electrochemical detection. RESULTS: Baseline levels of DA an
d 5-HT in dialysates were 56 +/- 16 and 3 +/- 0.6 fmol/20 mu l, respec
tively. Administration of phentermine (2 or 5 mg/kg) increased dialysa
te DA concentrations to 147 +/- 17% (P < 0.01) and 320 +/- 89% (P (0.0
1) of baseline, respectively, without significantly affecting 5-HT con
centrations. Pretreatment with tetrodotoxin (TTX, 60 min, 1 mu M), whi
ch abolished the basal release of DA and 5-HT into striatal dialysates
, diminished the increase in DA concentrations induced by phentermine,
but did not completely block it. Phentermine (2 or 5 mg/kg, i.p.) sti
ll stimulated DA release to 27 +/- 13% and 85 +/- 15% of baseline, res
pectively, in the presence of TTX. CONCLUSION: Phentermine increases b
rain DA but not 5-HT release in freely moving rats, and TTX reduces, b
ut does not fully block this effect. This pattern is similar to that k
nown to be produced by d-amphetamine.